Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Nov 10 - Nov 15
AOD 9604: Chemical Identity AOD 9604 is a synthetic growth hormonederived peptide fragment corresponding to the C-terminal lipolytic region of human GH, with an additional N-terminal tyrosine residue incorporated to improve structural stability in laboratory systems
If you have a diagnosed B12 deficiencysuch as from pernicious anemia or certain gastrointestinal issuesyour initial treatment may involve weekly B12 injections for several weeks
Although severe allergic reactions are very rare, they have occurred
(4) Smith RL, Soeters MR, Wst RCI, Houtkooper RH
[2] Patients should contact their GP if they experience: Side effects from B12 injections (though these are rare and usually mild) Difficulty attending scheduled injection appointments, as missed doses may lead to symptom recurrence New symptoms developing during treatment Concerns about treatment effectiveness or duration Changes in other medications that might affect B12 absorption Suspected adverse reactions to B12 treatment can be reported through the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk)
US$ 26.38
US$ 26.39
US$ 28.90
US$ 23.52
